A British medical trial on puberty blocking drugs will involve girls as young as 11 years old, despite the government banning such drugs for children in 2024.
The UK government’s Medicines and Healthcare Products Regulatory Agency (MHRA) said on Friday that the previously paused Pathways transgender medical trial is set to go ahead in August after being paused in February.
The controversial trial will see young girls as young as 11 and boys as young as 12 being given puberty blockers to study their impact, London’s Daily Telegraph reported.
In 2024, left-wing Labour Party Health Secretary Wes Streeting suspended the use of puberty blocking…
Read the full article at BREITBART.COM
